Newborn Screening Market Scope And Analysis

Report Code : TIPHE100001294
Category : Life Sciences

Status : Published
No. of Pages : 226

Buy Now

Newborn Screening Market Analysis Report 2023 to 2030

Buy Now

Newborn Screening Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 1,206.74 Million
Market Size by 2030	US$ 2,484.16 Million
Global CAGR (2022 - 2030)	9.40%
Historical Data	2020-2021
Forecast period	2023-2030
Segments Covered	By Product Type Reagents and Assay Kits Instruments By Technology Tandem Mass Spectrometry Molecular Assays Immunoassays and Enzymatic Assays Pulse Oximetry Screening Technology By Test Type Dry Blood Spot Test Hearing Screen Test Critical Congenital Heart Diseases Test By End User Hospitals and Clinics Diagnostic Laboratories
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	LifeCell International Pvt Ltd Zentech SA Trivitron Healthcare Pvt Ltd PerkinElmer Inc Waters Corp Bio Rad Laboratories Inc Masimo Corp Natus Medical Inc Baebies Inc MRC Holland BV

Newborn Screening Market News and Recent Developments

The newborn screening market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the newborn screening market are listed below:

Rady Children’s Institute for Genomic Medicine (RCIGM) announced a novel program to advance and evaluate the scalability of a diagnostic and precision medicine guidance tool called BeginNGS (pronounced “beginnings”) to screen newborns for approximately 400 genetic diseases that have known treatment options using rapid Whole Genome Sequencing (rWGS). BeginNGS, developed through a research collaboration with Alexion, AstraZeneca’s Rare Disease group; Fabric Genomics; Genomenon; Illumina, Inc.; and TileDB, uses rWGS to diagnose and identify treatment options for genetic conditions before symptoms begin, an advancement over current pediatric uses of rWGS that focus mainly on children who are already critically ill. (Source: Rady Children's Institute for Genomic Medicine, Press Release, June 2022)

Newborn Screening Market Report Coverage and Deliverables

The “Newborn Screening Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

Newborn screening market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Newborn screening market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
Newborn screening market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the newborn screening market
Detailed company profiles